CAPPS KATHLEEN S. (See Remarks) sold 3.7% of their position (323.00 shares) of ENANTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $4.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2025ACC: 0002064832-25-000070
Officer· See Remarks
Since Aug 2025
-323.00
Net shares
Net seller
$4.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
323.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−323.00
Price / share
$14.23
Trade value
$4.60K
% of position
3.7%
12/5/2025
8.70K→8.38K
Total
Net shares
−323.00
Net value
-$4.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | S · Sale | −323.00 | $14.23 | $4.60K | 3.7% | 8.70K | 8.38K |
| Total | −323.00 | -$4.60K | ||||||
Derivative Transactions0
No derivative transactions reported